✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹25,867 Cr.
P/E
42.51
About
Pfizer Limited is a pharmaceutical company involved in the manufacturing, marketing, trading, and export of pharmaceutical products. It operates with its own manufacturing facility in Goa and has part… Read more
Pfizer Limited is a pharmaceutical company involved in the manufacturing, marketing, trading, … Read more
Low
3838
52W Range
High
6451
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Custom financial statement
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
20 %
(as of Mar 24)
Antacid (Gelucil) - Market Share
0 %
(as of Jul 22)
Anti - Diabetes - Market Share
2.98 %
(as of Jul 22)
Anti-Infectives - Market Share
0.14 %
(as of May 19)
Anti-Malarial - Market Share
67 %
(as of Mar 24)
Anticholinergics ( Pacitane) - Market Share
2.34 %
(as of Nov 21)
Antineo Plastic - Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    Peer Comparison
    Brands
    Autrin
    Becosules
    Corex Dx
    Gelusil
    Ovral L
    Suppliers
    • Tata Communications Ltd.
    • Piramal Enterprises Ltd.
    • Aarti Industries Ltd.
    • AGI Greenpac Ltd.
    • Aarti Drugs Ltd.
    FAQs on Pfizer Ltd. Business

    Pfizer Limited is a pharmaceutical company that manufactures, markets & exports products from its manufacturing facility in Goa, India. They have many product portfolios including therapeutics & vaccines that focus on clearly defined areas.

    Pfizer major competitors are JB Chem & Pharma, Alembic Pharma, Natco Pharma, Gland Pharma, Astrazeneca Pharma I, Eris Lifesciences, Jubilant Pharmova.
    Market Cap of Pfizer is ₹25,867 Crs.
    While the median market cap of its peers are ₹23,971 Crs.

    Pfizer seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis